| Patent Number |
Title Of Patent |
Date Issued |
| RE38629 |
Solid oral dosage form comprising a combination of metformin and glibenclamide |
October 19, 2004 |
| The present invention relates to a solid oral dosage form comprising a combination of metformin and glibenclamide in which the size of glibenclamide is such that the glibenclamide bioavailability is comparable to the glibenclamide bioavailability obtained with a separate administrati |
| 7482484 |
Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia |
January 27, 2009 |
| Disclosed are Compounds of formula I ##STR00001## And methods of use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes. |
| 7465752 |
Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions c |
December 16, 2008 |
| Compounds of the formula (I): ##STR00001## in which R, R.sup.1, R.sup.2 and R.sup.3 are as defined in the description, to their use for the treatment of dyslipidaemia, atherosclerosis and diabetes, to pharmaceutical compositions comprising them and to the processes for the prepara |
| 6512009 |
Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and |
January 28, 2003 |
| A pharmaceutical composition for the treatment of alcohol and drug dependence, comprising a therapeutically effective amount of a combination of: (i) an opioid antagonist; and (ii) a NMDA receptor complex modulator. A pharmaceutical kit is also provided, comprising these two substances. |
| 6372790 |
Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for th |
April 16, 2002 |
| A pharmaceutical composition comprising: (i) metformin, optionally in the form one of its pharmaceutically acceptable salts; (ii) a fibrate selected from fenofibrate and bezafibrate; and optionally one or more pharmaceutically acceptable excipients, is suitable for use in the treatme |
| 6303146 |
Solid oral dosage form comprising a combination of metformin and glibenclamide |
October 16, 2001 |
| The present invention relates to a solid oral dosage form comprising a combination of metformin and glibenclamide in which the size of glibenclamide is such that the glibenclamide bioavailability is comparable to the glibenclamide bioavailability obtained with a separate administrati |
